These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20834029)

  • 1. Monitoring of the anticoagulants argatroban and lepirudin: a comparison of laboratory methods.
    Ivandic B; Zorn M
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):549-55. PubMed ID: 20834029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of Argatroban and Lepirudin: What is the Input of Laboratory Values in "Real Life"?
    Seidel H; Kolde HJ
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):287-294. PubMed ID: 28320219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful?
    Curvers J; van de Kerkhof D; Stroobants AK; van den Dool EJ; Scharnhorst V
    Am J Clin Pathol; 2012 Oct; 138(4):551-8. PubMed ID: 23010710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.
    Beiderlinden M; Werner P; Bahlmann A; Kemper J; Brezina T; Schäfer M; Görlinger K; Seidel H; Kienbaum P; Treschan TA
    BMC Anesthesiol; 2018 Feb; 18(1):18. PubMed ID: 29426286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.
    Warkentin TE; Greinacher A; Craven S; Dewar L; Sheppard JA; Ofosu FA
    Thromb Haemost; 2005 Nov; 94(5):958-64. PubMed ID: 16363236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.
    Gosselin RC; King JH; Janatpour KA; Dager WE; Larkin EC; Owings JT
    Ann Pharmacother; 2004 Sep; 38(9):1383-8. PubMed ID: 15238620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients.
    Beyer JT; Lind SE; Fisher S; Trujillo TC; Wempe MF; Kiser TH
    J Thromb Thrombolysis; 2020 Feb; 49(2):259-267. PubMed ID: 31559512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors.
    Van Cott EM; Roberts AJ; Dager WE
    Semin Thromb Hemost; 2017 Apr; 43(3):270-276. PubMed ID: 28052306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of anticoagulant effects of direct thrombin inhibitors.
    Fenyvesi T; Jörg I; Harenberg J
    Semin Thromb Hemost; 2002 Aug; 28(4):361-8. PubMed ID: 12244483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting Time.
    Harder S; Graff J; Klinkhardt U; von Hentig N; Walenga JM; Watanabe H; Osakabe M; Breddin HK
    Thromb Haemost; 2004 Jun; 91(6):1137-45. PubMed ID: 15175800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant activity and pharmacokinetic properties of a sub-cutaneously administered mixed micellar formulation of argatroban in experimental animals.
    Berry CN; Lunven C; Lecoffre C; Lainée P; O'Connor SE; André F; Roger B; Garrigou-Gadenne D; Rouchouse A; Roome NO; Vivan N
    Thromb Haemost; 2000 Aug; 84(2):278-85. PubMed ID: 10959701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples.
    Lind SE; Boyle ME; Fisher S; Ishimoto J; Trujillo TC; Kiser TH
    Am J Clin Pathol; 2014 May; 141(5):665-74. PubMed ID: 24713737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values.
    Gosselin RC; Dager WE; King JH; Janatpour K; Mahackian K; Larkin EC; Owings JT
    Am J Clin Pathol; 2004 Apr; 121(4):593-9. PubMed ID: 15080313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia.
    John TE; Hallisey RK
    Pharmacotherapy; 2005 Oct; 25(10):1383-8. PubMed ID: 16185183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of the activated partial thromboplastin time and dilute thrombin time to argatroban: Results of an in vitro study.
    Scalambrino E; Padovan L; Chantarangkul V; Clerici M; Artoni A; Peyvandi F; Tripodi A
    Int J Lab Hematol; 2020 Jun; 42(3):e128-e131. PubMed ID: 32086868
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phenprocoumon on monitoring of lepirudin, argatroban, melagatran and unfractionated heparin with the PiCT method.
    Fenyvesi T; Jörg I; Harenberg J
    Pathophysiol Haemost Thromb; 2002; 32(4):174-9. PubMed ID: 12759518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database.
    Moffett BS; Teruya J
    Arch Pathol Lab Med; 2014 Sep; 138(9):1229-32. PubMed ID: 25171706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of monitoring methods for lepirudin: impact of warfarin and lupus anticoagulant.
    Salmela B; Joutsi-Korhonen L; Saarela E; Lassila R
    Thromb Res; 2010 Jun; 125(6):538-44. PubMed ID: 20181379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.